sign in sign up
<<
Home , Alphacetylmethadol, Metopon, Myrophine, Piminodine, Proheptazine, Racemoramide

Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices 21999

Drug Schedule Drug Schedule Administration, that the requirements for such registration pursuant to 21 HCl (9059) ...... I (9150) ...... II U.S.C. 958(a); 21 U.S.C. 823(a); and 21 methylbromide (9070) .... I (9170) ...... II CFR 1301.34(b), (c), (d), (e), and (f) are (9145) ...... I Benzoylecgonine (9180) ...... II satisfied. (9168) ...... I (9190) ...... II (9200) ...... I (9193) ...... II Dated: April 2, 2012. (9301) ...... I (9210) ...... II Joseph T. Rannazzisi, (9302) ...... I (9220) ...... II Deputy Assistant Administrator, Office of (9304) ..... I (9226) ...... II Diversion Control, Drug Enforcement methylbromide (9305) .. I Meperidine (9230) ...... II Administration. Morphine methylsulfonate (9306) I Meperidine intermediate-B (9233) II Morphine-N-oxide (9307) ...... I (9240) ...... II [FR Doc. 2012–8763 Filed 4–11–12; 8:45 am] (9308) ...... I (9250) ...... II BILLING CODE 4410–09–P (9309) ...... I Methadone intermediate (9254) ... II (9312) ...... I (9260) ...... II (9313) ...... I , bulk (non- II DEPARTMENT OF JUSTICE (9314) ...... I dosage forms) (9273). (9319) ...... I Morphine (9300) ...... II Drug Enforcement Administration (9601) ...... I (9333) ...... II (9602) ...... I (9334) ...... II Importer of Controlled Substances; except levo- I Levo-alphacetylmethadol (9648) .. II Notice Of Registration; Cerilliant alphacetyl-methadol (9603). (9652) ...... II Corporation (9605) ...... I (9668) ...... II (9621) ...... I (9715) ...... II By Notice dated January 6, 2012, and (9622) ...... I (9730) ...... II published in the Federal Register on (9623) .... I Racemethorphan (9732) ...... II January 17, 2012, 77 FR 2321, Cerilliant (9624) ...... I (9733) ...... II Corporation, 811 Paloma Drive, Suite A, (9625) ...... I (9737) ...... II Round Rock, Texas 78665–2402, made (9626) ...... I (9739) ...... II application by renewal to the Drug (9627) ...... I (9740) ...... II (9628) ...... I (9743) ...... II Enforcement Administration (DEA) to Levomoramide (9629) ...... I (9780) ...... II be registered as an importer of the (9631) ...... I (9800) ...... II following basic classes of controlled (9632) ...... I (9801) ...... II substances: (9633) ...... I (9634) ...... I The company plans to import Drug Schedule (9635) ...... I analytical reference standards for (9636) ...... I distribution to its customers for research Cathinone (1235) ...... I (9637) ...... I Methcathinone (1237) ...... I (9638) ...... I and analytical purposes. N-Ethylamphetamine (1475) ...... I (9641) ...... I Any bulk manufacturer who is N,N-Dimethylamphetamine (1480) I (9642) ...... I presently, or is applying to be, Fenethylline (1503) ...... I (9643) ...... I registered with DEA to manufacture Gamma Hydroxybutyric Acid I (9644) ...... I such basic classes of controlled (2010). (9645) ...... I substances may file comments or Alpha-ethyltryptamine (7249) ...... I (9646) ...... I objections to the issuance of the (7260) ...... I (9647) ...... I proposed registration, and may, at the Lysergic acid diethylamide (7315) I Levo-alphacetylmethadol (9648) .. I same time, file a written request for a Drug Schedule. (9649) ...... I 2,5-Dimethoxy-4-(n)- I (9750) ...... I hearing on such application pursuant to propylthiophenethylamine Para-Fluorofentanyl (9812) ...... I 21 CFR 1301.43, and in such form as (7348). 3–Methylfentanyl (9813) ...... I prescribed by 21 CFR 1316.47. Marihuana (7360) ...... I Acetyl-alpha-methylfentanyl I Any such comments or objections (7370) ..... I (9815). should be addressed, in quintuplicate, Mescaline (7381) ...... I Amphetamine (1100) ...... II to the Drug Enforcement 3,4,5-Trimethoxyamphetamine I Methamphetamine (1105) ...... II Administration, Office of Diversion (7390). Lisdexamfetamine (1205) ...... II Control, Federal Register Representative 4-Bromo-2,5- I Phenmetrazine (1631) ...... II (ODL), 8701 Morrissette Drive, dimethoxyamphetamine (7391). Methylphenidate (1724) ...... II 4-Bromo-2,5- I Amobarbital (2125) ...... II Springfield, Virginia 22152; and must be dimethoxyphenethylamine (2270) ...... II filed no later than May 14, 2012. (7392). Secobarbital (2315) ...... II This procedure is to be conducted 4-Methyl-2,5- I Glutethimide (2550) ...... II simultaneously with, and independent dimethoxyamphetamine (7395). (7379) ...... II of, the procedures described in 21 CFR 2,5-Dimethoxyamphetamine I 1–Phenylcyclohexylamine (7460) II 1301.34(b), (c), (d), (e), and (f). As noted (7396). (7471) ...... II in a previous notice published in the 3,4-Methylenedioxyamphetamine I 4–Anilino-N-phenethyl-4-piper- II Federal Register on September 23, 1975, (7400). idine (8333). 40 FR 43745–46, all applicants for 3,4-Methylenedioxy-N- I Phenylacetone (8501) ...... II registration to import a basic class of ethylamphetamine (7404). Alphaprodine (9010) ...... II 3,4- I (9020) ...... II any controlled substance in schedule I Methylenedioxymethamphetam- (9041) ...... II or II are, and will continue to be, ine (7405). Codeine (9050) ...... II required to demonstrate to the Deputy 4-Methoxyamphetamine (7411) ... I (9120) ...... II Assistant Administrator, Office of 5-Methoxy-N-N- I (9143) ...... II Diversion Control, Drug Enforcement dimethyltryptamine (7431).

VerDate Mar<15>2010 16:27 Apr 11, 2012 Jkt 226001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\12APN1.SGM 12APN1 mstockstill on DSK4VPTVN1PROD with NOTICES 22000 Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices

Drug Schedule Cerilliant Corporation to ensure that the FOR FURTHER INFORMATION CONTACT: Will company’s registration is consistent Bronson, Designated Federal Official Alpha-methyltryptamine (7432) .... I with the public interest. The (DFO), Deputy Associate Administrator, Diethyltryptamine (7434) ...... I investigation has included inspection Child Protection Division, Office of Dimethyltryptamine (7435) ...... I and testing of the company’s physical Juvenile Justice & Delinquency Psilocybin (7437) ...... I security systems, verification of the Psilocyn (7438) ...... I Prevention, Office of Justice Programs, 5-Methoxy-N,N- I company’s compliance with state and 810 7th Street NW., Washington, DC diisopropyltryptamine (7439). local laws, and a review of the 20531. Phone: (202) 305–2427 [note: N-Benzylpiperazine (7493) ...... I company’s background and history. this is not a toll-free number]; email: Etorphine (except HCl) (9056) ..... I Therefore, pursuant to 21 U.S.C. 952(a) [email protected]. Heroin (9200) ...... I and 958(a), and in accordance with 21 Morphine-N-oxide (9307) ...... I CFR 1301.34, the above named company SUPPLEMENTARY INFORMATION: This Normorphine (9313) ...... I is granted registration as an importer of hearing is being convened to brief the Pholcodine (9314) ...... I the basic classes of controlled task force members about the issue of (9613) ...... I children’s exposure to violence. The Dipipanone (9622) ...... I substances listed. Racemoramide (9645) ...... I Dated: April 2, 2012. final agenda is subject to adjustment, but it is anticipated that on April 23, Drug Schedule. Joseph T. Rannazzisi, there will be an evening session devoted Trimeperidine (9646) ...... I Deputy Assistant Administrator, Office of Tilidine (9750) ...... I Diversion Control, Drug Enforcement to public testimony. On April 24, there Amphetamine (1100) ...... II Administration. will be a morning and afternoon session, Methamphetamine (1105) ...... II [FR Doc. 2012–8766 Filed 4–11–12; 8:45 am] with a break for lunch. The morning Methylphenidate (1724) ...... II session will likely include welcoming Amobarbital (2125) ...... II BILLING CODE 4410–09–P Pentobarbital (2270) ...... II remarks, introductions, and panel Secobarbital (2315) ...... II presentations from invited guests on the Phencyclidine (7471) ...... II DEPARTMENT OF JUSTICE impact of children’s exposure to Phenylacetone (8501) ...... II violence. The afternoon session will Cocaine (9041) ...... II Office of Justice Programs continue with panel presentations from Codeine (9050) ...... II invited guests. April 25 will likely be Dihydrocodeine (9120) ...... II [OJP (OJJDP) Docket No. 1586] devoted to a working meeting of task Oxycodone (9143) ...... II force members. Hydromorphone (9150) ...... II Hearing of the Attorney General’s Benzoylecgonine (9180) ...... II This meeting is open to the public. National Task Force on Children Ethylmorphine (9190) ...... II Members of the public who wish to Exposed to Violence Meperidine (9230) ...... II attend this meeting must provide photo Methadone (9250) ...... II AGENCY: identification upon entering the hearing Dextropropoxyphene, bulk (non- II Office of Justice Programs dosage forms) (9273). (OJP), Justice. facility. Access to the meeting will not Morphine (9300) ...... II ACTION: Notice of hearing. be allowed without identification. In (9330) ...... II order to best prepare for attendees, Thebaine (9333) ...... II SUMMARY: This is an announcement of members of the public who wish to Levo-alphacetylmethadol (9648) .. II the fourth hearing of the Attorney attend this meeting may register with Oxymorphone (9652) ...... II General’s National Task Force on Will Bronson at defendingchildhood Concentrate (9670) II Children Exposed to Violence (the ‘‘task [email protected] in advance of the Fentanyl (9801) ...... II force’’). The task force is chartered to meeting. Registrations will be accepted provide OJP, a component of the The company plans to import small on a space available basis. Prior Department of Justice, with valuable registration is not required to attend this quantities of the listed controlled advice in the areas of children exposed substances for the manufacture of event, but is required for those who to violence for the purpose of wish to provide testimony. analytical reference standards. addressing the epidemic levels of In reference to drug codes 7360 and exposure to violence faced by our Time for public testimony is 7370, the company plans to import a nation’s children. Based on the scheduled from 5 p.m. to 7 p.m. Eastern synthetic and a synthetic testimony at four public hearings; on April 23. Public testimony must be . No other activity comprehensive research; and extensive provided in person and will be limited for this drug code is authorized for this input from experts, advocates, and to three (3) minutes per witness. registration. impacted families and communities Members of the public who wish to Comments and requests for hearings provide testimony must register with on applications to import raw nationwide, the task force will issue a Will Bronson at defendingchildhoodtask material are not appropriate, 72 FR 3417 final report to the Attorney General [email protected] by April 20. Please (2007). Regarding all other basic classes presenting its findings and bring photo identification and allow of controlled substances, no comments comprehensive policy recommendations extra time prior to the meeting. Persons or objections have been received. DEA in the fall of 2012. has considered the factors in 21 U.S.C. DATES: The hearing will take place on interested in communicating with the 823(a) and 952(a) and determined that Monday, April 23; Tuesday, April 24; task force should submit their written the registration of Cerilliant Corporation and Wednesday, April 25, 2012. comments to the DFO at defendingchild [email protected], as the time to import the basic classes of controlled ADDRESSES: The hearing will take place substances is consistent with the public at Wayne State University in the available will not allow the public to interest and with United States Bernath Auditorium on the first floor of directly address the task force (except as obligations under international treaties, the David Adamany Undergraduate provided above) at the meeting. conventions, or protocols in effect on Library, 5155 Gullen Mall, Detroit, MI Anyone requiring special May 1, 1971. DEA has investigated 48202. accommodations should notify Mr.

VerDate Mar<15>2010 16:27 Apr 11, 2012 Jkt 226001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\12APN1.SGM 12APN1 mstockstill on DSK4VPTVN1PROD with NOTICES